nodes	percent_of_prediction	percent_of_DWPC	metapath
Lopinavir—CYP2D6—Fingolimod—multiple sclerosis	0.117	0.119	CbGbCtD
Lopinavir—ABCB1—Methylprednisolone—multiple sclerosis	0.0797	0.0816	CbGbCtD
Lopinavir—CYP3A4—Fingolimod—multiple sclerosis	0.0741	0.0759	CbGbCtD
Lopinavir—CYP2C19—Prednisone—multiple sclerosis	0.0598	0.0613	CbGbCtD
Lopinavir—CYP2B6—Dexamethasone—multiple sclerosis	0.0588	0.0602	CbGbCtD
Lopinavir—ABCB1—Mitoxantrone—multiple sclerosis	0.0581	0.0595	CbGbCtD
Lopinavir—ABCB1—Betamethasone—multiple sclerosis	0.0518	0.053	CbGbCtD
Lopinavir—ABCB1—Prednisolone—multiple sclerosis	0.0511	0.0523	CbGbCtD
Lopinavir—ABCB1—Prednisone—multiple sclerosis	0.0483	0.0494	CbGbCtD
Lopinavir—CYP3A4—Methylprednisolone—multiple sclerosis	0.0477	0.0489	CbGbCtD
Lopinavir—CYP2C19—Dexamethasone—multiple sclerosis	0.0374	0.0382	CbGbCtD
Lopinavir—CYP3A4—Triamcinolone—multiple sclerosis	0.0362	0.037	CbGbCtD
Lopinavir—CYP3A4—Mitoxantrone—multiple sclerosis	0.0348	0.0357	CbGbCtD
Lopinavir—CYP2C9—Dexamethasone—multiple sclerosis	0.0311	0.0318	CbGbCtD
Lopinavir—CYP3A4—Betamethasone—multiple sclerosis	0.031	0.0318	CbGbCtD
Lopinavir—CYP3A4—Prednisolone—multiple sclerosis	0.0306	0.0314	CbGbCtD
Lopinavir—ABCB1—Dexamethasone—multiple sclerosis	0.0301	0.0309	CbGbCtD
Lopinavir—CYP3A4—Prednisone—multiple sclerosis	0.0289	0.0296	CbGbCtD
Lopinavir—CYP2D6—Dexamethasone—multiple sclerosis	0.0284	0.0291	CbGbCtD
Lopinavir—ABCB1—Methotrexate—multiple sclerosis	0.0242	0.0248	CbGbCtD
Lopinavir—CYP3A4—Dexamethasone—multiple sclerosis	0.0181	0.0185	CbGbCtD
Lopinavir—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000598	0.0258	CbGpPWpGaD
Lopinavir—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000598	0.0258	CbGpPWpGaD
Lopinavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000441	0.0191	CbGpPWpGaD
Lopinavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000441	0.0191	CbGpPWpGaD
Lopinavir—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000412	0.0178	CbGpPWpGaD
Lopinavir—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000412	0.0178	CbGpPWpGaD
Lopinavir—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00038	0.0164	CbGpPWpGaD
Lopinavir—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00038	0.0164	CbGpPWpGaD
Lopinavir—CYP2B6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000375	0.0162	CbGpPWpGaD
Lopinavir—CYP2B6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000375	0.0162	CbGpPWpGaD
Lopinavir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000352	0.0152	CbGpPWpGaD
Lopinavir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000352	0.0152	CbGpPWpGaD
Lopinavir—CYP2B6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000308	0.0133	CbGpPWpGaD
Lopinavir—CYP2B6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000308	0.0133	CbGpPWpGaD
Lopinavir—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000287	0.0124	CbGpPWpGaD
Lopinavir—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000287	0.0124	CbGpPWpGaD
Lopinavir—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000283	0.0122	CbGpPWpGaD
Lopinavir—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000283	0.0122	CbGpPWpGaD
Lopinavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000272	0.0117	CbGpPWpGaD
Lopinavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000272	0.0117	CbGpPWpGaD
Lopinavir—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000264	0.0114	CbGpPWpGaD
Lopinavir—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000264	0.0114	CbGpPWpGaD
Lopinavir—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000262	0.0113	CbGpPWpGaD
Lopinavir—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000262	0.0113	CbGpPWpGaD
Lopinavir—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00026	0.0113	CbGpPWpGaD
Lopinavir—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00026	0.0113	CbGpPWpGaD
Lopinavir—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000258	0.0112	CbGpPWpGaD
Lopinavir—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000258	0.0112	CbGpPWpGaD
Lopinavir—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000251	0.0109	CbGpPWpGaD
Lopinavir—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000241	0.0104	CbGpPWpGaD
Lopinavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000233	0.01	CbGpPWpGaD
Lopinavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000233	0.01	CbGpPWpGaD
Lopinavir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000224	0.00966	CbGpPWpGaD
Lopinavir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000224	0.00966	CbGpPWpGaD
Lopinavir—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000221	0.00953	CbGpPWpGaD
Lopinavir—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000221	0.00953	CbGpPWpGaD
Lopinavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000214	0.00924	CbGpPWpGaD
Lopinavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000214	0.00924	CbGpPWpGaD
Lopinavir—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000212	0.00916	CbGpPWpGaD
Lopinavir—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000212	0.00916	CbGpPWpGaD
Lopinavir—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000196	0.00845	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000192	0.00828	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.000191	0.00825	CbGpPWpGaD
Lopinavir—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000181	0.00783	CbGpPWpGaD
Lopinavir—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000181	0.00783	CbGpPWpGaD
Lopinavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000173	0.00745	CbGpPWpGaD
Lopinavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000173	0.00745	CbGpPWpGaD
Lopinavir—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00017	0.00736	CbGpPWpGaD
Lopinavir—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00017	0.00736	CbGpPWpGaD
Lopinavir—CYP2B6—Biological oxidations—CYP27B1—multiple sclerosis	0.000164	0.00706	CbGpPWpGaD
Lopinavir—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	0.000164	0.00706	CbGpPWpGaD
Lopinavir—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000161	0.00697	CbGpPWpGaD
Lopinavir—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000161	0.00697	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000156	0.00673	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000156	0.00673	CbGpPWpGaD
Lopinavir—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000155	0.00669	CbGpPWpGaD
Lopinavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000144	0.00623	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000142	0.00612	CbGpPWpGaD
Lopinavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00014	0.00604	CbGpPWpGaD
Lopinavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00014	0.00604	CbGpPWpGaD
Lopinavir—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000135	0.00582	CbGpPWpGaD
Lopinavir—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000134	0.00581	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000134	0.00577	CbGpPWpGaD
Lopinavir—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000124	0.00534	CbGpPWpGaD
Lopinavir—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000124	0.00534	CbGpPWpGaD
Lopinavir—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000124	0.00534	CbGpPWpGaD
Lopinavir—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000122	0.00526	CbGpPWpGaD
Lopinavir—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000122	0.00526	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000121	0.00524	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.00012	0.0052	CbGpPWpGaD
Lopinavir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000115	0.00498	CbGpPWpGaD
Lopinavir—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000114	0.00491	CbGpPWpGaD
Lopinavir—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000114	0.00491	CbGpPWpGaD
Lopinavir—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000113	0.00487	CbGpPWpGaD
Lopinavir—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000113	0.00487	CbGpPWpGaD
Lopinavir—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000112	0.00484	CbGpPWpGaD
Lopinavir—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000112	0.00484	CbGpPWpGaD
Lopinavir—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000111	0.0048	CbGpPWpGaD
Lopinavir—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000111	0.0048	CbGpPWpGaD
Lopinavir—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000106	0.00459	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000105	0.00455	CbGpPWpGaD
Lopinavir—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000105	0.00452	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000102	0.00442	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	9.78e-05	0.00423	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	9.7e-05	0.00419	CbGpPWpGaD
Lopinavir—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	9.63e-05	0.00416	CbGpPWpGaD
Lopinavir—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	9.63e-05	0.00416	CbGpPWpGaD
Lopinavir—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.5e-05	0.0041	CbGpPWpGaD
Lopinavir—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.5e-05	0.0041	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—CD40—multiple sclerosis	9.33e-05	0.00403	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	9.2e-05	0.00397	CbGpPWpGaD
Lopinavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	8.89e-05	0.00384	CbGpPWpGaD
Lopinavir—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.54e-05	0.00369	CbGpPWpGaD
Lopinavir—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	8.41e-05	0.00363	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	8.1e-05	0.0035	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	7.57e-05	0.00327	CbGpPWpGaD
Lopinavir—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	7.43e-05	0.00321	CbGpPWpGaD
Lopinavir—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	7.43e-05	0.00321	CbGpPWpGaD
Lopinavir—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.33e-05	0.00317	CbGpPWpGaD
Lopinavir—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.33e-05	0.00317	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—CD86—multiple sclerosis	7.29e-05	0.00315	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	7.15e-05	0.00309	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—IL10—multiple sclerosis	7.15e-05	0.00309	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—IL4—multiple sclerosis	6.96e-05	0.00301	CbGpPWpGaD
Lopinavir—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.93e-05	0.00299	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	6.8e-05	0.00294	CbGpPWpGaD
Lopinavir—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.46e-05	0.00279	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—FAS—multiple sclerosis	6.41e-05	0.00277	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	6.38e-05	0.00275	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	6.3e-05	0.00272	CbGpPWpGaD
Lopinavir—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.94e-05	0.00256	CbGpPWpGaD
Lopinavir—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.89e-05	0.00254	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	5.76e-05	0.00249	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—CD80—multiple sclerosis	5.32e-05	0.0023	CbGpPWpGaD
Lopinavir—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.23e-05	0.00226	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	5.18e-05	0.00224	CbGpPWpGaD
Lopinavir—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.03e-05	0.00217	CbGpPWpGaD
Lopinavir—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.81e-05	0.00208	CbGpPWpGaD
Lopinavir—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.77e-05	0.00206	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.75e-05	0.00205	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.75e-05	0.00205	CbGpPWpGaD
Lopinavir—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.74e-05	0.00205	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	4.62e-05	0.00199	CbGpPWpGaD
Lopinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.61e-05	0.00199	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	4.6e-05	0.00199	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.33e-05	0.00187	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.33e-05	0.00187	CbGpPWpGaD
Lopinavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	4.28e-05	0.00185	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	4.21e-05	0.00182	CbGpPWpGaD
Lopinavir—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.08e-05	0.00176	CbGpPWpGaD
Lopinavir—CYP2B6—Metabolism—SRM—multiple sclerosis	3.97e-05	0.00171	CbGpPWpGaD
Lopinavir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.88e-05	0.00168	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.75e-05	0.00162	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.74e-05	0.00161	CbGpPWpGaD
Lopinavir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.7e-05	0.0016	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.7e-05	0.0016	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.7e-05	0.0016	CbGpPWpGaD
Lopinavir—CYP2B6—Biological oxidations—POMC—multiple sclerosis	3.68e-05	0.00159	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	3.6e-05	0.00155	CbGpPWpGaD
Lopinavir—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.59e-05	0.00155	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	3.59e-05	0.00155	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	3.52e-05	0.00152	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	3.35e-05	0.00145	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3.35e-05	0.00145	CbGpPWpGaD
Lopinavir—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.16e-05	0.00137	CbGpPWpGaD
Lopinavir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.15e-05	0.00136	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism—SRM—multiple sclerosis	3e-05	0.0013	CbGpPWpGaD
Lopinavir—ABCB1—Metabolism—SRM—multiple sclerosis	2.93e-05	0.00126	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.92e-05	0.00126	CbGpPWpGaD
Lopinavir—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.84e-05	0.00123	CbGpPWpGaD
Lopinavir—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	2.8e-05	0.00121	CbGpPWpGaD
Lopinavir—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	2.8e-05	0.00121	CbGpPWpGaD
Lopinavir—CYP2C19—Biological oxidations—POMC—multiple sclerosis	2.78e-05	0.0012	CbGpPWpGaD
Lopinavir—CYP2D6—Metabolism—SRM—multiple sclerosis	2.76e-05	0.00119	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism—SRM—multiple sclerosis	2.74e-05	0.00118	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.72e-05	0.00118	CbGpPWpGaD
Lopinavir—CYP2B6—Metabolism—GPC5—multiple sclerosis	2.56e-05	0.0011	CbGpPWpGaD
Lopinavir—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.56e-05	0.0011	CbGpPWpGaD
Lopinavir—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.53e-05	0.00109	CbGpPWpGaD
Lopinavir—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.51e-05	0.00108	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism—SRM—multiple sclerosis	2.34e-05	0.00101	CbGpPWpGaD
Lopinavir—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.17e-05	0.000936	CbGpPWpGaD
Lopinavir—CYP2B6—Metabolism—RRM1—multiple sclerosis	2.12e-05	0.000915	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.11e-05	0.000913	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.11e-05	0.000913	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.07e-05	0.000892	CbGpPWpGaD
Lopinavir—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.06e-05	0.000891	CbGpPWpGaD
Lopinavir—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.06e-05	0.000891	CbGpPWpGaD
Lopinavir—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.94e-05	0.00084	CbGpPWpGaD
Lopinavir—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.94e-05	0.00084	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.93e-05	0.000835	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.93e-05	0.000832	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.93e-05	0.000832	CbGpPWpGaD
Lopinavir—ABCB1—Metabolism—GPC5—multiple sclerosis	1.89e-05	0.000815	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.88e-05	0.000813	CbGpPWpGaD
Lopinavir—CYP3A4—Metabolism—SRM—multiple sclerosis	1.8e-05	0.000779	CbGpPWpGaD
Lopinavir—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.78e-05	0.000768	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.76e-05	0.000761	CbGpPWpGaD
Lopinavir—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.67e-05	0.000722	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.65e-05	0.000711	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.65e-05	0.000711	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.61e-05	0.000695	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.6e-05	0.000692	CbGpPWpGaD
Lopinavir—ABCB1—Metabolism—RRM1—multiple sclerosis	1.56e-05	0.000675	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.51e-05	0.000651	CbGpPWpGaD
Lopinavir—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.47e-05	0.000636	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.46e-05	0.000631	CbGpPWpGaD
Lopinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.44e-05	0.000623	CbGpPWpGaD
Lopinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.44e-05	0.000621	CbGpPWpGaD
Lopinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.41e-05	0.000609	CbGpPWpGaD
Lopinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.34e-05	0.00058	CbGpPWpGaD
Lopinavir—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.27e-05	0.000549	CbGpPWpGaD
Lopinavir—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.27e-05	0.000549	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.25e-05	0.000539	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.24e-05	0.000537	CbGpPWpGaD
Lopinavir—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.22e-05	0.000526	CbGpPWpGaD
Lopinavir—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.16e-05	0.000502	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.13e-05	0.000489	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.07e-05	0.000461	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.73e-06	0.00042	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.73e-06	0.00042	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.68e-06	0.000418	CbGpPWpGaD
Lopinavir—CYP3A4—Metabolism—RRM1—multiple sclerosis	9.63e-06	0.000416	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism—BCHE—multiple sclerosis	9.2e-06	0.000397	CbGpPWpGaD
Lopinavir—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.03e-06	0.00039	CbGpPWpGaD
Lopinavir—ABCB1—Metabolism—BCHE—multiple sclerosis	8.98e-06	0.000388	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.87e-06	0.000383	CbGpPWpGaD
Lopinavir—CYP2D6—Metabolism—BCHE—multiple sclerosis	8.46e-06	0.000365	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism—BCHE—multiple sclerosis	8.39e-06	0.000362	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.32e-06	0.000359	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.58e-06	0.000328	CbGpPWpGaD
Lopinavir—CYP2B6—Metabolism—APOE—multiple sclerosis	7.32e-06	0.000316	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism—BCHE—multiple sclerosis	7.17e-06	0.00031	CbGpPWpGaD
Lopinavir—CYP2B6—Metabolism—POMC—multiple sclerosis	6.29e-06	0.000272	CbGpPWpGaD
Lopinavir—CYP2B6—Metabolism—ALB—multiple sclerosis	5.74e-06	0.000248	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism—APOE—multiple sclerosis	5.53e-06	0.000239	CbGpPWpGaD
Lopinavir—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.53e-06	0.000239	CbGpPWpGaD
Lopinavir—ABCB1—Metabolism—APOE—multiple sclerosis	5.4e-06	0.000233	CbGpPWpGaD
Lopinavir—CYP2D6—Metabolism—APOE—multiple sclerosis	5.09e-06	0.00022	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism—APOE—multiple sclerosis	5.05e-06	0.000218	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism—POMC—multiple sclerosis	4.75e-06	0.000205	CbGpPWpGaD
Lopinavir—ABCB1—Metabolism—POMC—multiple sclerosis	4.64e-06	0.0002	CbGpPWpGaD
Lopinavir—CYP2D6—Metabolism—POMC—multiple sclerosis	4.37e-06	0.000189	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism—POMC—multiple sclerosis	4.33e-06	0.000187	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism—ALB—multiple sclerosis	4.33e-06	0.000187	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism—APOE—multiple sclerosis	4.31e-06	0.000186	CbGpPWpGaD
Lopinavir—ABCB1—Metabolism—ALB—multiple sclerosis	4.23e-06	0.000183	CbGpPWpGaD
Lopinavir—CYP2D6—Metabolism—ALB—multiple sclerosis	3.99e-06	0.000172	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism—ALB—multiple sclerosis	3.95e-06	0.000171	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism—POMC—multiple sclerosis	3.7e-06	0.00016	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism—ALB—multiple sclerosis	3.38e-06	0.000146	CbGpPWpGaD
Lopinavir—CYP3A4—Metabolism—APOE—multiple sclerosis	3.33e-06	0.000144	CbGpPWpGaD
Lopinavir—CYP3A4—Metabolism—POMC—multiple sclerosis	2.86e-06	0.000123	CbGpPWpGaD
Lopinavir—CYP3A4—Metabolism—ALB—multiple sclerosis	2.61e-06	0.000113	CbGpPWpGaD
